A- A A+
Last Updated : May 5 2021 10:28PM     Screen Reader Access
News Highlights
Govt says, 12 States and UTs showing early signs of reduction in COVID-19 cases            Over 3.38 lakh people recover from COVID-19 in last 24 hours            PM Narendra Modi praises healthcare workers and nurses for reducing vaccine wastage            Centre reviews availability of drugs for COVID treatment; Union Minister Sadananda Gowda says, increased production capacity of Remdesivir will augment domestic availability of injection            RBI announces on-tap liquidity window of Rs 50,000 crore to ramp up COVID related health care infrastructure and services in country           

International News

Nov 20, 2020
8:37PM

Oxford-AstraZeneca vaccine shows strong immune response in elderly

AIR
The Oxford-AstraZeneca Covid-19 vaccine candidate shows a strong immune response in adults in their 60s and 70s, according to researchers, raising hopes that it can protect age groups most at risk from the virus.

Researchers say the Lancet phase two findings, based on 560 healthy adult volunteers, are encouraging.

Three vaccines - Pfizer-BioNTech, Sputnik and Moderna - have already reported good preliminary data from phase three trials, with one suggesting 94% of people over 65 could be protected from Covid-19.

Older people's weaker immune systems generally mean vaccines do not tend to function as well as they do in younger people. But, these trial results from the University of Oxford, peer-reviewed in the Lancet, suggest that may not be a problem. They show that older adults aged 56-69 and over 70 had a similar immune response to younger adults aged 18-55.

Dr Maheshi Ramasamy, an investigator at the Oxford Vaccine Group, said two weeks after the second dose, more than 99% of participants of all ages had neutralising antibody responses.

The T-cell response - another measure of how well the immune system responds - peaked two weeks after the first dose of the vaccine, regardless of age.

The robust antibody and T-cell responses seen in older people in the study are encouraging, Dr Ramasamy said.  The populations at greatest risk of serious Covid-19 disease include people with existing health conditions and older adults and hence, this vaccine may help to protect some of the most vulnerable people in society, he said.

   Related News

Live Twitter Feed

Listen News

Morning News 5 (May) Midday News 5 (May) Evening News 5 (May) Hourly 5 (May) (1910hrs)
समाचार प्रभात 5 (May) दोपहर समाचार 5 (May) समाचार संध्या 5 (May) प्रति घंटा समाचार 5 (May) (2200hrs)
Khabarnama (Mor) 5 (May) Khabrein(Day) 5 (May) Khabrein(Eve) 5 (May)
Aaj Savere 28 (Apr) Parikrama 28 (Apr)

Listen Programs

Market Mantra 5 (May) Samayki 1 (Jan) Sports Scan 5 (May) Spotlight/News Analysis 5 (May) Employment News 5 (May) रोजगार समाचार 5 (May) World News 4 (May) Samachar Darshan 22 (Mar) Radio Newsreel 21 (Mar)
    Public Speak

    Country wide 12 (Mar) Surkhiyon Mein 5 (May) Charcha Ka Vishai Ha 11 (Mar) Vaad-Samvaad 17 (Mar) Money Talk 17 (Mar) Current Affairs 6 (Mar) Sanskrit Saptahiki 1 (May) North East Diary 2 (May)